Turkey
Bioeksen R&D Technologies, established in 2014, is a prominent player within the Biotechnology and Health Care industries. Based in Turkey, the company specializes in the development of molecular diagnostic products using Reverse Transcription and Real-Time Polymerase Chain Reaction technologies (qPCR and RT-qPCR). Their slogan, "Bio-Speedy® , Molecular Diagnostic, R&D , Biotechnology," encapsulates their mission to accelerate advancements in health diagnostics.
With ISO 13485 and ISO 9001 certifications, Bioeksen operates production facilities in Istanbul and Hannover (Germany), boasting a robust daily production capacity of 2 million tests. A standout in the global market, Bioeksen ranks in the top 5% of the 580 biotechnology companies approved by the World Health Organization (WHO) and the US Food and Drug Administration (FDA).
Having successfully completed 32 R&D projects, Bioeksen has introduced 180 molecular biotechnology products, resulting in sales of over 200 million tests across 85 countries. This esteemed company, driven by its commitment to quality and sustainability, remains unaffiliated with any outside investors, presenting an enticing opportunity for strategic partnerships and investment.
